Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Anti-inflammatory and immunomodulatory" refers to a broad category of therapeutic approaches rather than a specific molecular target. These therapies aim to modify immune system function to treat various conditions including autoimmune diseases, inflammatory disorders, cancer, and neurodegenerative diseases. Immunomodulators can either enhance (immunostimulants) or suppress (immunosuppressants) immune responses. They target various molecular pathways including cytokine signaling, leukocyte activation, and cell adhesion. Specific molecular targets within this category include proinflammatory cytokines, their receptors, adhesion molecules, and various signaling pathways like NF-κB. Drug classes include biologics (such as monoclonal antibodies), small molecules, peptides, and natural products.
Inhibition of cytokine signaling, Decreasing leukocyte activation, Reducing chemotaxis and recruitment, Targeting proinflammatory cytokines and their receptors, Modulating adhesion molecules
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anti-inflammatory and immunomodulatory.